Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/28/76/ea/2876eaac-65f5-72b4-c164-4f714cb2c146/mza_15714996188315364471.png/600x600bb.jpg
Atypical dementias: from diagnosis to emerging therapies
ICGEB
14 episodes
5 months ago
Dementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years. At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, progressive nuclear palsy and Parkinson dementia. Often, these atypical dementias are associated with neurological symptoms and with motor neuron disease. Understanding the molecular basis of these dementias, their diagnosis, clinical implications, and diagnostic issues, currently represents one of the most pressing issues worldwide. For this reason, the meeting topics are of high interest for the whole scientific community. The meeting will foster targeted emerging areas of research in this field. In parallel, it also plans to integrate and disseminate current knowledge on the subject. The subject areas of the Meeting will mostly be concerned with the several forms of atypical dementias that are on the rise in both developed and developing countries. This will particularly include leading conceptual advances that arise from the study of early and late stage pathological neurodegeneration. As a result, the meeting will be positioned to provide invaluable guidance for other scientists, governing bodies, and the general population towards the best ways of lessening the impact of dementia, both at the macro-economical and individual human level.
Show more...
Science
RSS
All content for Atypical dementias: from diagnosis to emerging therapies is the property of ICGEB and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years. At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, progressive nuclear palsy and Parkinson dementia. Often, these atypical dementias are associated with neurological symptoms and with motor neuron disease. Understanding the molecular basis of these dementias, their diagnosis, clinical implications, and diagnostic issues, currently represents one of the most pressing issues worldwide. For this reason, the meeting topics are of high interest for the whole scientific community. The meeting will foster targeted emerging areas of research in this field. In parallel, it also plans to integrate and disseminate current knowledge on the subject. The subject areas of the Meeting will mostly be concerned with the several forms of atypical dementias that are on the rise in both developed and developing countries. This will particularly include leading conceptual advances that arise from the study of early and late stage pathological neurodegeneration. As a result, the meeting will be positioned to provide invaluable guidance for other scientists, governing bodies, and the general population towards the best ways of lessening the impact of dementia, both at the macro-economical and individual human level.
Show more...
Science
Episodes (14/14)
Atypical dementias: from diagnosis to emerging therapies
F. Ranieri - The contribution of non-invasive brain stimulation in the diagnosis and management of dementia
Federico Ranieri, Rome, Italy speaks on "The contribution of non-invasive brain stimulation in the diagnosis and management of dementia". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
23 minutes

Atypical dementias: from diagnosis to emerging therapies
M. Onofrj - EEG in Dementia with Lewy Body
Marco Onofrj, Chieti, Italy speaks on "EEG in Dementia with Lewy Body". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
27 minutes

Atypical dementias: from diagnosis to emerging therapies
Z. Walker - Progress in diagnosis of Dementia with Lewy Bodies
Zuzana Walker, UCL, UK London on "Progress in diagnosis of Dementia with Lewy Bodies". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
25 minutes

Atypical dementias: from diagnosis to emerging therapies
Z. Miller - Co-occurrence of autoimmune disease within atypical dementias
Zachary Miller, San Francisco, USA speaks on "Co-occurrence of autoimmune disease within atypical dementias". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
32 minutes

Atypical dementias: from diagnosis to emerging therapies
A. Bruni - Niemann-pick C: when diseases don't respect borders
Amalia Bruni, Lamezia Terme, Italy speaks on "Niemann-pick C: when diseases don't respect borders". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
21 minutes

Atypical dementias: from diagnosis to emerging therapies
G. Zanusso - Advances in human prion disorders diagnosis
Gianluigi Zanusso, Verona, Italy speaks on "Advances in human prion disorders diagnosis". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
31 minutes

Atypical dementias: from diagnosis to emerging therapies
A. Padovani - The emerging picture of early Alzheimer's Disease
Alessandro Padovani, Brescia, Italy speaks on "The emerging picture of early Alzheimer's Disease". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
28 minutes

Atypical dementias: from diagnosis to emerging therapies
F. Tagliavini - New insights into Cerebral Amyloid Angiopathy
Fabrizio Tagliavini, Milan, Italy speaks on "New insights into Cerebral Amyloid Angiopathy". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
30 minutes

Atypical dementias: from diagnosis to emerging therapies
B. Dubois - New criteria of Alzheimer Disease: the atypical cases
Bruno Dubois, Paris, France speaks on "New criteria of Alzheimer Disease: the atypical cases". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
26 minutes

Atypical dementias: from diagnosis to emerging therapies
P. Fratta - TDP-43: C-terminal mutations induce a splicing gain of function
Pietro Fratta, London, UK speaks on "TDP-43: C-terminal mutations induce a splicing gain of function". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
23 minutes

Atypical dementias: from diagnosis to emerging therapies
J. Rowe - Neuroimaging in Frontotemporal Dementia
James Rowe, Cambridge, UK speaks on "Neuroimaging in Frontotemporal Dementia". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
28 minutes

Atypical dementias: from diagnosis to emerging therapies
I. Mackenzie - Molecular neuropathology of FTD: recent developments
Ian Mackenzie, Vancouver, Canada speaks on "Molecular neuropathology of FTD: recent developments". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
32 minutes

Atypical dementias: from diagnosis to emerging therapies
T. Bak - Clinical aspects of Primary Progressive Aphasia
Thomas Bak, Edinburgh, UK speaks on "Clinical aspects of Primary Progressive Aphasia". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
29 minutes

Atypical dementias: from diagnosis to emerging therapies
P. Heutink - Risk and modifying factors in Fronto Temporal Dementia (RiMod-FTD)
Peter Heutink, Tubingen, Germany speaks on "Risk and Modifying factots in to Fronto Temporal Dementia (RiMod-FTD)". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Show more...
7 years ago
26 minutes

Atypical dementias: from diagnosis to emerging therapies
Dementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years. At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, progressive nuclear palsy and Parkinson dementia. Often, these atypical dementias are associated with neurological symptoms and with motor neuron disease. Understanding the molecular basis of these dementias, their diagnosis, clinical implications, and diagnostic issues, currently represents one of the most pressing issues worldwide. For this reason, the meeting topics are of high interest for the whole scientific community. The meeting will foster targeted emerging areas of research in this field. In parallel, it also plans to integrate and disseminate current knowledge on the subject. The subject areas of the Meeting will mostly be concerned with the several forms of atypical dementias that are on the rise in both developed and developing countries. This will particularly include leading conceptual advances that arise from the study of early and late stage pathological neurodegeneration. As a result, the meeting will be positioned to provide invaluable guidance for other scientists, governing bodies, and the general population towards the best ways of lessening the impact of dementia, both at the macro-economical and individual human level.